CAM
DGX icon

Chesapeake Asset Management’s Quest Diagnostics DGX Stock Holding History

Chesapeake Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-700
Closed -$98.4K – 449
2023
Q2 		$98.4K Hold
700
– – 0.09% 114
2023
Q1 		$99K Buy
+700
New +$100K 0.09% 114

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Chesapeake Asset Management's DGX Position: Q3 2023 in Review

Chesapeake Asset Management sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 700 shares — an estimated $98.4K sold.

Chesapeake Asset Management first reported a position in DGX in Q1 2023 and held it in 2 quarters. The position peaked at $99K in Q1 2023. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Chesapeake Asset Management reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Chesapeake Asset Management sold 700 Quest Diagnostics shares in Q3 2023, an estimated $98.4K.
  • Chesapeake Asset Management first reported a position in Quest Diagnostics in Q1 2023 and held it in 2 quarters.
  • Chesapeake Asset Management's Quest Diagnostics position peaked at $99K in Q1 2023.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Chesapeake Asset Management's 13F filing for Q3 2023, filed 5 Jan 2026.